Symbol="CTMX"
AssetType="Common Stock"
Name="CytomX Therapeutics Inc"
Description="CytomX Therapeutics, Inc. is an oncology-focused biopharmaceutical company in the United States. The company is headquartered in South San Francisco, California."
CIK="1501989"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="97518000"
EBITDA="-38084000"
PERatio="None"
PEGRatio="-1.8"
BookValue="-1.273"
DividendPerShare="0"
DividendYield="0"
EPS="-1.03"
RevenuePerShareTTM="1.201"
ProfitMargin="-0.531"
OperatingMarginTTM="-0.51"
ReturnOnAssetsTTM="-0.108"
ReturnOnEquityTTM="-54.75"
RevenueTTM="79493000"
GrossProfitTTM="53163000"
DilutedEPSTTM="-1.03"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.924"
AnalystTargetPrice="2.49"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.447"
PriceToBookRatio="3.806"
EVToRevenue="0.743"
EVToEBITDA="0.694"
Beta="0.625"
num_52WeekHigh="3.02"
num_52WeekLow="1.17"
num_50DayMovingAverage="1.676"
num_200DayMovingAverage="1.829"
SharesOutstanding="66339000"
DividendDate="None"
ExDividendDate="None"
symbol="CTMX"
open="1.46"
high="1.52"
low="1.45"
price="1.47"
volume="207055.00"
latest_trading_day="2023-08-18"
previous_close="1.49"
change="-0.02"
change_percent="-1.3423%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="91"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="9"
Volume_recent_avg="440613"
Change_recent_avg="0.01"
Delta_recent_avg="0.08"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.1"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="9"
Aroon_momentum_negative="91"
image_negative_thumbnail_id_1="165"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0011.jpeg"
image_negative_thumbnail_id_2="92"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0084.jpeg"
image_neutral_thumbnail_id_1="598"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_neutral_thumbnail_id_2="565"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_positive_thumbnail_id_1="993"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0155.jpeg"
image_positive_thumbnail_id_2="703"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0005.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
